Mitogen-Activated Protein Kinase Pathways are Involved in the Upregulation of Calcitonin Gene-Related Peptide of Rat Trigeminal Ganglion After Organ Culture

The trigeminal ganglion (TG) can express and release calcitonin gene-related peptide (CGRP), an important neuropeptide that plays a crucial role in migraine attack and cluster headache. Activation of rat TG increases CGRP expression. However, the regulatory mechanism of CGRP expression in TG neurons remains to be explored. This study aims to evaluate the involvement of mitogen-activated protein kinase (MAPK) pathways in CGRP upregulation after rat TG organ culture. Rat TG was cultured alone for 24 h or cultured in combination with MAPK inhibitors, tumor necrosis factor α (TNF-α), or interleukin 1β (IL-1β) for 24 h. CGRP protein was determined using immunohistochemistry. The mRNA levels of CGRP, TNF-α, and IL-1β were analyzed through real-time quantitative polymerase chain reaction. MAPK phosphorylation was detected via western blot. After rat TG organ culture, the expressions of CGRP, TNF-α, and IL-1β were upregulated at 24 h. The phosphorylation of extracellular signal-regulated kinases (ERK1/2), P38, and c-jun N-terminal kinases (JNK) significantly increased at 30 min compared with fresh rat TG. In addition, both CGRP expression and phosphorylation of ERK1/2, P38, and JNK were enhanced obviously after rat TG treatment with TNF-α or IL-1β compared with fresh rat TG. However, they decreased markedly after rat TG pretreatment with PD98059 (ERK1/2 inhibitor), SB203580 (P38 inhibitor), or SP600125 (JNK inhibitor) compared with rat TG co-culture with TNF-α or IL-1β. In conclusion, the elevated CGRP expression after rat TG organ culture can be regulated via MAPK pathways. The findings provide insight into the molecular mechanisms and experimental evidence for therapeutic targets of migraine.

[1]  L. Edvinsson.  New therapeutic target in primary headaches – blocking the CGRP receptor , 2003, Expert opinion on therapeutic targets.

[2]  P. Durham,et al.  Neuron–Glia Signaling in Trigeminal Ganglion: Implications for Migraine Pathology , 2007, Headache.

[3]  M. Hanani.  Satellite glial cells in sensory ganglia: from form to function , 2005, Brain Research Reviews.

[4]  Xianglin Shi,et al.  Opposite Effect of NF-κB and c-Jun N-terminal Kinase on p53-independent GADD45 Induction by Arsenite* , 2001, The Journal of Biological Chemistry.

[5]  G. Juhász,et al.  NO-induced migraine attack: strong increase in plasma calcitonin gene-related peptide (CGRP) concentration and negative correlation with platelet serotonin release , 2003, Pain.

[6]  Benjamin E. Deverman,et al.  Cytokines and CNS Development , 2009, Neuron.

[7]  T. Olsson,et al.  Cytokine responses during chronic denervation , 2005, Journal of Neuroinflammation.

[8]  Karl Messlinger,et al.  Calcitonin receptor‐like receptor (CLR), receptor activity‐modifying protein 1 (RAMP1), and calcitonin gene‐related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: Differences between peripheral and central CGRP receptor distribution , 2008, The Journal of comparative neurology.

[9]  M. Roisin,et al.  Tumor Necrosis Factor α Activates the Phosphorylation of ERK, SAPK/JNK, and P38 Kinase in Primary Cultures of Neurons , 2001, Neurochemical Research.

[10]  H. Schaeffer,et al.  Mitogen-Activated Protein Kinases: Specific Messages from Ubiquitous Messengers , 1999, Molecular and Cellular Biology.

[11]  R. Lipton,et al.  Migraine--current understanding and treatment. , 2002, The New England journal of medicine.

[12]  R. Ji,et al.  Activation of JNK pathway in persistent pain , 2008, Neuroscience Letters.

[13]  S. Bloom,et al.  Differential expression of α-CGRP and β-CGRP by primary sensory neurons and enteric autonomic neurons of the rat , 1988, Neuroscience.

[14]  John G. Collard,et al.  The Rac activator Tiam1 prevents keratinocyte apoptosis by controlling ROS-mediated ERK phosphorylation , 2008, Journal of Cell Science.

[15]  J. Tajti,et al.  Differential Distribution of Calcitonin Gene-related Peptide (cgrp) and Its Receptor Components in the Human Trigeminal Ganglion , 2022 .

[16]  P. Durham,et al.  Tumor necrosis factor‐α stimulation of calcitonin gene‐related peptide expression and secretion from rat trigeminal ganglion neurons , 2006 .

[17]  S. Amara,et al.  Differential expression of alpha-CGRP and beta-CGRP by primary sensory neurons and enteric autonomic neurons of the rat. , 1988, Neuroscience.

[18]  Junichi Kitagawa,et al.  Enhanced excitability of nociceptive trigeminal ganglion neurons by satellite glial cytokine following peripheral inflammation , 2007, Pain.

[19]  P. Reeh,et al.  ATP can enhance the proton-induced CGRP release through P2Y receptors and secondary PGE2 release in isolated rat dura mater , 2002, Pain.

[20]  Yi Dai,et al.  Role of Mitogen-Activated Protein Kinase Activation in Injured and Intact Primary Afferent Neurons for Mechanical and Heat Hypersensitivity after Spinal Nerve Ligation , 2004, The Journal of Neuroscience.

[21]  U. Dirnagl,et al.  IL-1β Stimulates COX-2 Dependent PGE2 Synthesis and CGRP Release in Rat Trigeminal Ganglia Cells , 2011, PloS one.

[22]  L. Swanson,et al.  Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing , 1983, Nature.

[23]  Ferrari,et al.  Drug therapy: Migraine - Current understanding and treatment. , 2002 .

[24]  Hilmar Bading,et al.  Nuclear calcium signaling controls CREB-mediated gene expression triggered by synaptic activity , 2001, Nature Neuroscience.

[25]  Nancy Y. Ip,et al.  ERKs: A family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF , 1991, Cell.

[26]  C. Woolf,et al.  p38 MAPK Activation by NGF in Primary Sensory Neurons after Inflammation Increases TRPV1 Levels and Maintains Heat Hyperalgesia , 2002, Neuron.

[27]  I. Trocóniz,et al.  Modelling the Anti-Migraine Effects of BIBN 4096 BS , 2006, Clinical pharmacokinetics.

[28]  Ping-Heng Tan,et al.  Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain , 2008, Nature Medicine.

[29]  I. Fidan,et al.  The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine , 2006, Journal of Neuroimmunology.

[30]  C. Svensson,et al.  Selective increase of tumour necrosis factor‐alpha in injured and spared myelinated primary afferents after chronic constrictive injury of rat sciatic nerve , 2003, The European journal of neuroscience.

[31]  D. Clapham,et al.  Phosphatidylinositol 3-Kinase Activates ERK in Primary Sensory Neurons and Mediates Inflammatory Heat Hyperalgesia through TRPV1 Sensitization , 2004, The Journal of Neuroscience.

[32]  J. Olesen,et al.  Cgrp May Play A Causative Role in Migraine , 2002, Cephalalgia : an international journal of headache.

[33]  Jiahuai Han,et al.  Pro-inflammatory Cytokines and Environmental Stress Cause p38 Mitogen-activated Protein Kinase Activation by Dual Phosphorylation on Tyrosine and Threonine (*) , 1995, The Journal of Biological Chemistry.

[34]  M. Zimmermann,et al.  Ethical guidelines for investigations of experimental pain in conscious animals , 1983, Pain.

[35]  J. McCubrey,et al.  Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention , 2003, Leukemia.

[36]  P. Goadsby,et al.  Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system , 1988, Annals of neurology.

[37]  R. Quirion,et al.  Neuroanatomical Localization, Pharmacological Characterization and Functions of CGRP, Related Peptides and Their Receptors , 1997, Neuroscience & Biobehavioral Reviews.

[38]  L. Edvinsson,et al.  Neurogenic inflammation: a study of rat trigeminal ganglion , 2010, The Journal of Headache and Pain.

[39]  L. Edvinsson,et al.  Expression of inducible nitric oxide synthase in trigeminal ganglion cells during culture. , 2005, Basic & clinical pharmacology & toxicology.

[40]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[41]  J. Olesen,et al.  Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. , 2004, The New England journal of medicine.

[42]  H. Lee,et al.  Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model , 2004, Neuroreport.

[43]  J. Boehm,et al.  p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases , 2003, Nature Reviews Drug Discovery.

[44]  C. Woolf,et al.  Central sensitization: a generator of pain hypersensitivity by central neural plasticity. , 2009, The journal of pain : official journal of the American Pain Society.

[45]  J. Tajti,et al.  Organ culture of the trigeminal ganglion induces enhanced expression of calcitonin gene-related peptide via activation of extracellular signal-regulated protein kinase 1/2 , 2011, Cephalalgia : an international journal of headache.

[46]  D. Storm,et al.  Making New Connections Role of ERK/MAP Kinase Signaling in Neuronal Plasticity , 1999, Neuron.

[47]  David Julius,et al.  Cellular and Molecular Mechanisms of Pain , 2009, Cell.

[48]  S. Zhuang,et al.  p38 Mitogen-activated Protein Kinase Mediates Bid Cleavage, Mitochondrial Dysfunction, and Caspase-3 Activation during Apoptosis Induced by Singlet Oxygen but Not by Hydrogen Peroxide* , 2000, The Journal of Biological Chemistry.

[49]  A. Turjanski,et al.  MAP kinases and the control of nuclear events , 2007, Oncogene.

[50]  K. Ren,et al.  Role of interleukin-1β during pain and inflammation , 2009, Brain Research Reviews.

[51]  R. Ji.  Peripheral and central mechanisms of inflammatory pain, with emphasis on MAP kinases. , 2004, Current drug targets. Inflammation and allergy.

[52]  A. Capuano,et al.  Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology , 2009, Molecular pain.

[53]  W. Sobaniec,et al.  Proinflammatory plasma cytokines in children with migraine. , 2009, Pediatric neurology.

[54]  C. Sommer,et al.  Early cytokine expression in mouse sciatic nerve after chronic constriction nerve injury depends on calpain , 2007, Brain, Behavior, and Immunity.

[55]  L. Becerra,et al.  Challenges of functional imaging research of pain in children , 2009, Molecular pain.

[56]  C. Widmann,et al.  Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. , 1999, Physiological reviews.

[57]  J. Woodgett,et al.  The stress-activated protein kinase subfamily of c-Jun kinases , 1994, Nature.

[58]  E. Fabbretti,et al.  Calcitonin Gene-Related Peptide-Mediated Enhancement of Purinergic Neuron/Glia Communication by the Algogenic Factor Bradykinin in Mouse Trigeminal Ganglia from Wild-Type and R192Q Cav2.1 Knock-In Mice: Implications for Basic Mechanisms of Migraine Pain , 2011, The Journal of Neuroscience.

[59]  L. Edvinsson.  Blockade of CGRP Receptors in the Intracranial Vasculature: A New Target in the Treatment of Headache , 2004, Cephalalgia : an international journal of headache.